Citation Impact
Citing Papers
DNA Damage–Specific Control of Cell Death by Cryptochrome in p53-Mutant Ras–Transformed Cells
2012 StandoutNobel
Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
1993
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Separation methods for anthraquinone related anti-cancer drugs
2001
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
2005
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
2009
Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities
2004
Cell production rates in human tissues and tumours and their significance. Part II: clinical data
2000
Apoptosis in cancer
2000 Standout
Tumor spectrum analysis in p53-mutant mice
1994 Standout
p53, the Cellular Gatekeeper for Growth and Division
1997 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Expression of anaplastic lymphoma kinase in soft tissue tumors: An immunohistochemical and molecular study of 249 cases
2004
Anaplastic lymphoma kinase proteins in growth control and cancer
2004
Inflammatory Myofibroblastic Tumor
2007 Standout
Autophagy regulates lipid metabolism
2009 StandoutNature
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Over‐expression and amplification of the CDC2 gene in leukaemia cells
1995
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Inflammatory myofibroblastic tumours: where are we now?
2007 Standout
High-performance liquid chromatographic methods for the determination of topoisomerase II inhibitors
2001
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
1996 StandoutNature
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
2010 Standout
Spontaneously Occurring Tumors of Companion Animals as Models for Human Cancer
2000 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
State of the art in hair analysis for detection of drug and alcohol abuse
2006 Standout
Neurogenesis in the adult human hippocampus
1998 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Identification of CARS-ALK Fusion in Primary and Metastatic Lesions of an Inflammatory Myofibroblastic Tumor
2003
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells
1998 Standout
A measure of the mitotic index: studies of the abundance and half‐life of p34cdc2 in cultured cells and normal and neoplastic tissues
1998 StandoutNobel
Analysis of anticancer drugs: A review
2011 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
The Psychosocial Impact of Completing Childhood Cancer Treatment: A Systematic Review of the Literature
2009
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
1999 StandoutNobel
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Natural compounds for cancer treatment and prevention
2009 Standout
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 Standout
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
1994 Standout
Ratiometric measurement of intracellular pH in cultured human keratinocytes using carboxy‐SNARF‐1 and flow cytometry
1991
Cell cycle control and cancer chemotherapy
1994 StandoutNobel
Neuropathic Pain Activates the Endogenous κ Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance
2004 StandoutNobel
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics
1995
Regional, developmental, and cell cycle-dependent differences in ?, ?, and ?-opioid receptor expression among cultured mouse astrocytes
1998
Prognostic value of S‐phase cells in AML patients
1995
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
REGULATION OF IMMUNE RESPONSES BY TGF-β
1998 Standout
Mechanisms of DNA Excision Repair
1994 StandoutScienceNobel
Cancer Cell Cycles
1996 StandoutScience
Targeting ALK: Precision Medicine Takes on Drug Resistance
2017
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics
1995
Mechanisms of Cancer Drug Resistance
2002 Standout
Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry
1992
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
1995 Standout
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
2005
Unique Substrate Specificity of Anaplastic Lymphoma Kinase (ALK): Development of Phosphoacceptor Peptides for the Assay of ALK Activity
2005
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
1994 StandoutNobel
Impact of heterogeneity in the predictive value of kinetic parameters in canine osteosarcoma.
1994
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
1994 Standout
Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor beta.
1994
Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry
1992
Anaplastic lymphoma kinase: signalling in development and disease
2009
Mucocutaneous junction as the major source of replacement palpebral conjunctival epithelial cells.
1999
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
1995 StandoutNobel
Works of Paul Brons being referenced
Longitudinal assessment of health‐related quality of life in preschool children with non‐CNS cancer after the end of successful treatment
2007
Simultaneous measurement of DNA content and cell‐surface immunofluorescence of human bone marrow cells using a single laser flow cytometer
1990
Determination of amsacrine in human nucleated hematopoietic cells
1987
Plasma and cellular pharmacokinetics of m‐AMSA related to in vitro toxicity towards normal and leukemic clonogenic bone marrow cells (CFU‐GM, CFU‐L)
1993
Chapter 6 Simultaneous DNA Content and Cell-Surface Immunofluorescence Analysis
1994
A rapid flow cytometric method for bivariate bromodeoxyuridine/DNA analysis using simultaneous proteolytic enzyme digestion and acid denaturation
1988
ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma
2003
Cell cycle kinetics in normal human skin by in vivo administration of iododeoxyuridine and application of a differentiation marker--implications for cell cycle kinetics in psoriatic skin.
1996
S-phase DNA content and aneuploidy of immunophenotypic defined subpopulations in acute myeloid leukemia determined by multi-parameter flow cytometry
1991